Industry: Service & Software
Published Date: 2025-07-16
Pages: 126 Pages
Report ld: 4793050
Request Sample
Customized Report
Microbiota Transplantation Service Market Size(US$)

CAGR 2025-2031
5.4%
Market Size,2031
USD 433
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Microbiota Transplantation Service was estimated to be worth US$ 301 million in 2024 and is forecast to a readjusted size of US$ 433 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Microbiota transplantation service refers to the treatment of intestinal microbiota (usually from fecal samples) from healthy donors and then transplanted into the patient's intestines to rebuild or regulate the intestinal microecological balance, thereby improving intestinal-related diseases or other systemic diseases. This service usually includes donor screening, sample preparation, clinical transplantation operations (such as colonoscopy injection, capsule oral administration, etc.) and postoperative follow-up, and is widely used in the fields of Clostridium difficile infection, inflammatory bowel disease, autoimmune diseases, etc.
North American market for Microbiota Transplantation Service was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Microbiota Transplantation Service was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Microbiota Transplantation Service was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Microbiota Transplantation Service include Seres Therapeutics, Finch Therapeutics, OpenBiome, Vedanta Biosciences, MaaT Pharma, BiomX, Entera Health, Metabiomics, J-Pharma, Hangzhou Shengshi Technology, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Microbiota Transplantation Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Microbiota Transplantation Service by region & country, by Type, and by Application.
The Microbiota Transplantation Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbiota Transplantation Service.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Microbiota Transplantation Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Microbiota Transplantation Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Microbiota Transplantation Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Microbiota Transplantation Service Product Introduction
1.2 Global Microbiota Transplantation Service Market Size Forecast (2020-2031)
1.3 Microbiota Transplantation Service Market Trends & Drivers
1.3.1 Microbiota Transplantation Service Industry Trends
1.3.2 Microbiota Transplantation Service Market Drivers & Opportunity
1.3.3 Microbiota Transplantation Service Market Challenges
1.3.4 Microbiota Transplantation Service Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Microbiota Transplantation Service Players Revenue Ranking (2024)
2.2 Global Microbiota Transplantation Service Revenue by Company (2020-2025)
2.3 Key Companies Microbiota Transplantation Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Microbiota Transplantation Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Microbiota Transplantation Service
2.6 Microbiota Transplantation Service Market Competitive Analysis
2.6.1 Microbiota Transplantation Service Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Microbiota Transplantation Service Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiota Transplantation Service as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Traditional Intestinal Transplantation
3.1.2 Oral Capsule Transplantation
3.2 Global Microbiota Transplantation Service Sales Value by Type
3.2.1 Global Microbiota Transplantation Service Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Microbiota Transplantation Service Sales Value, by Type (2020-2031)
3.2.3 Global Microbiota Transplantation Service Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Medical Industry
4.1.2 Health Management Industry
4.1.3 Animal Health Industry
4.1.4 Others
4.2 Global Microbiota Transplantation Service Sales Value by Application
4.2.1 Global Microbiota Transplantation Service Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Microbiota Transplantation Service Sales Value, by Application (2020-2031)
4.2.3 Global Microbiota Transplantation Service Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Microbiota Transplantation Service Sales Value by Region
5.1.1 Global Microbiota Transplantation Service Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Microbiota Transplantation Service Sales Value by Region (2020-2025)
5.1.3 Global Microbiota Transplantation Service Sales Value by Region (2026-2031)
5.1.4 Global Microbiota Transplantation Service Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Microbiota Transplantation Service Sales Value, 2020-2031
5.2.2 North America Microbiota Transplantation Service Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Microbiota Transplantation Service Sales Value, 2020-2031
5.3.2 Europe Microbiota Transplantation Service Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Microbiota Transplantation Service Sales Value, 2020-2031
5.4.2 Asia Pacific Microbiota Transplantation Service Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Microbiota Transplantation Service Sales Value, 2020-2031
5.5.2 South America Microbiota Transplantation Service Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Microbiota Transplantation Service Sales Value, 2020-2031
5.6.2 Middle East & Africa Microbiota Transplantation Service Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Microbiota Transplantation Service Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Microbiota Transplantation Service Sales Value, 2020-2031
6.3 United States
6.3.1 United States Microbiota Transplantation Service Sales Value, 2020-2031
6.3.2 United States Microbiota Transplantation Service Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Microbiota Transplantation Service Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Microbiota Transplantation Service Sales Value, 2020-2031
6.4.2 Europe Microbiota Transplantation Service Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Microbiota Transplantation Service Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Microbiota Transplantation Service Sales Value, 2020-2031
6.5.2 China Microbiota Transplantation Service Sales Value by Type (%), 2024 VS 2031
6.5.3 China Microbiota Transplantation Service Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Microbiota Transplantation Service Sales Value, 2020-2031
6.6.2 Japan Microbiota Transplantation Service Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Microbiota Transplantation Service Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Microbiota Transplantation Service Sales Value, 2020-2031
6.7.2 South Korea Microbiota Transplantation Service Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Microbiota Transplantation Service Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Microbiota Transplantation Service Sales Value, 2020-2031
6.8.2 Southeast Asia Microbiota Transplantation Service Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Microbiota Transplantation Service Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Microbiota Transplantation Service Sales Value, 2020-2031
6.9.2 India Microbiota Transplantation Service Sales Value by Type (%), 2024 VS 2031
6.9.3 India Microbiota Transplantation Service Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Seres Therapeutics
7.1.1 Seres Therapeutics Profile
7.1.2 Seres Therapeutics Main Business
7.1.3 Seres Therapeutics Microbiota Transplantation Service Products, Services and Solutions
7.1.4 Seres Therapeutics Microbiota Transplantation Service Revenue (US$ Million) & (2020-2025)
7.1.5 Seres Therapeutics Recent Developments
7.2 Finch Therapeutics
7.2.1 Finch Therapeutics Profile
7.2.2 Finch Therapeutics Main Business
7.2.3 Finch Therapeutics Microbiota Transplantation Service Products, Services and Solutions
7.2.4 Finch Therapeutics Microbiota Transplantation Service Revenue (US$ Million) & (2020-2025)
7.2.5 Finch Therapeutics Recent Developments
7.3 OpenBiome
7.3.1 OpenBiome Profile
7.3.2 OpenBiome Main Business
7.3.3 OpenBiome Microbiota Transplantation Service Products, Services and Solutions
7.3.4 OpenBiome Microbiota Transplantation Service Revenue (US$ Million) & (2020-2025)
7.3.5 OpenBiome Recent Developments
7.4 Vedanta Biosciences
7.4.1 Vedanta Biosciences Profile
7.4.2 Vedanta Biosciences Main Business
7.4.3 Vedanta Biosciences Microbiota Transplantation Service Products, Services and Solutions
7.4.4 Vedanta Biosciences Microbiota Transplantation Service Revenue (US$ Million) & (2020-2025)
7.4.5 Vedanta Biosciences Recent Developments
7.5 MaaT Pharma
7.5.1 MaaT Pharma Profile
7.5.2 MaaT Pharma Main Business
7.5.3 MaaT Pharma Microbiota Transplantation Service Products, Services and Solutions
7.5.4 MaaT Pharma Microbiota Transplantation Service Revenue (US$ Million) & (2020-2025)
7.5.5 MaaT Pharma Recent Developments
7.6 BiomX
7.6.1 BiomX Profile
7.6.2 BiomX Main Business
7.6.3 BiomX Microbiota Transplantation Service Products, Services and Solutions
7.6.4 BiomX Microbiota Transplantation Service Revenue (US$ Million) & (2020-2025)
7.6.5 BiomX Recent Developments
7.7 Entera Health
7.7.1 Entera Health Profile
7.7.2 Entera Health Main Business
7.7.3 Entera Health Microbiota Transplantation Service Products, Services and Solutions
7.7.4 Entera Health Microbiota Transplantation Service Revenue (US$ Million) & (2020-2025)
7.7.5 Entera Health Recent Developments
7.8 Metabiomics
7.8.1 Metabiomics Profile
7.8.2 Metabiomics Main Business
7.8.3 Metabiomics Microbiota Transplantation Service Products, Services and Solutions
7.8.4 Metabiomics Microbiota Transplantation Service Revenue (US$ Million) & (2020-2025)
7.8.5 Metabiomics Recent Developments
7.9 J-Pharma
7.9.1 J-Pharma Profile
7.9.2 J-Pharma Main Business
7.9.3 J-Pharma Microbiota Transplantation Service Products, Services and Solutions
7.9.4 J-Pharma Microbiota Transplantation Service Revenue (US$ Million) & (2020-2025)
7.9.5 J-Pharma Recent Developments
7.10 Hangzhou Shengshi Technology
7.10.1 Hangzhou Shengshi Technology Profile
7.10.2 Hangzhou Shengshi Technology Main Business
7.10.3 Hangzhou Shengshi Technology Microbiota Transplantation Service Products, Services and Solutions
7.10.4 Hangzhou Shengshi Technology Microbiota Transplantation Service Revenue (US$ Million) & (2020-2025)
7.10.5 Hangzhou Shengshi Technology Recent Developments
7.11 Ruiyi Biotechnology
7.11.1 Ruiyi Biotechnology Profile
7.11.2 Ruiyi Biotechnology Main Business
7.11.3 Ruiyi Biotechnology Microbiota Transplantation Service Products, Services and Solutions
7.11.4 Ruiyi Biotechnology Microbiota Transplantation Service Revenue (US$ Million) & (2020-2025)
7.11.5 Ruiyi Biotechnology Recent Developments
7.12 Jiangsu Junkey Life Technology Development
7.12.1 Jiangsu Junkey Life Technology Development Profile
7.12.2 Jiangsu Junkey Life Technology Development Main Business
7.12.3 Jiangsu Junkey Life Technology Development Microbiota Transplantation Service Products, Services and Solutions
7.12.4 Jiangsu Junkey Life Technology Development Microbiota Transplantation Service Revenue (US$ Million) & (2020-2025)
7.12.5 Jiangsu Junkey Life Technology Development Recent Developments
7.13 Hangzhou Yuanxiang Medical Technology
7.13.1 Hangzhou Yuanxiang Medical Technology Profile
7.13.2 Hangzhou Yuanxiang Medical Technology Main Business
7.13.3 Hangzhou Yuanxiang Medical Technology Microbiota Transplantation Service Products, Services and Solutions
7.13.4 Hangzhou Yuanxiang Medical Technology Microbiota Transplantation Service Revenue (US$ Million) & (2020-2025)
7.13.5 Hangzhou Yuanxiang Medical Technology Recent Developments
7.14 MAUSOAR
7.14.1 MAUSOAR Profile
7.14.2 MAUSOAR Main Business
7.14.3 MAUSOAR Microbiota Transplantation Service Products, Services and Solutions
7.14.4 MAUSOAR Microbiota Transplantation Service Revenue (US$ Million) & (2020-2025)
7.14.5 MAUSOAR Recent Developments
7.15 Shanghai Chengge Biotechnology
7.15.1 Shanghai Chengge Biotechnology Profile
7.15.2 Shanghai Chengge Biotechnology Main Business
7.15.3 Shanghai Chengge Biotechnology Microbiota Transplantation Service Products, Services and Solutions
7.15.4 Shanghai Chengge Biotechnology Microbiota Transplantation Service Revenue (US$ Million) & (2020-2025)
7.15.5 Shanghai Chengge Biotechnology Recent Developments
7.16 Guangzhou Zhiyi Biotechnology
7.16.1 Guangzhou Zhiyi Biotechnology Profile
7.16.2 Guangzhou Zhiyi Biotechnology Main Business
7.16.3 Guangzhou Zhiyi Biotechnology Microbiota Transplantation Service Products, Services and Solutions
7.16.4 Guangzhou Zhiyi Biotechnology Microbiota Transplantation Service Revenue (US$ Million) & (2020-2025)
7.16.5 Guangzhou Zhiyi Biotechnology Recent Developments
7.17 Shenzhen Unknown Jun Biotechnology
7.17.1 Shenzhen Unknown Jun Biotechnology Profile
7.17.2 Shenzhen Unknown Jun Biotechnology Main Business
7.17.3 Shenzhen Unknown Jun Biotechnology Microbiota Transplantation Service Products, Services and Solutions
7.17.4 Shenzhen Unknown Jun Biotechnology Microbiota Transplantation Service Revenue (US$ Million) & (2020-2025)
7.17.5 Shenzhen Unknown Jun Biotechnology Recent Developments
7.18 Sichuan Anaerobic Biotechnology
7.18.1 Sichuan Anaerobic Biotechnology Profile
7.18.2 Sichuan Anaerobic Biotechnology Main Business
7.18.3 Sichuan Anaerobic Biotechnology Microbiota Transplantation Service Products, Services and Solutions
7.18.4 Sichuan Anaerobic Biotechnology Microbiota Transplantation Service Revenue (US$ Million) & (2020-2025)
7.18.5 Sichuan Anaerobic Biotechnology Recent Developments
8 Industry Chain Analysis
8.1 Microbiota Transplantation Service Industrial Chain
8.2 Microbiota Transplantation Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Microbiota Transplantation Service Sales Model
8.5.2 Sales Channel
8.5.3 Microbiota Transplantation Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Microbiota Transplantation Service market is projected to grow from US$ 316 million in 2025 to US$ 454 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 147
USD 4900.00
(Single User License)
The global Microbiota Transplantation Service market size was US$ 316 million in 2025 and is forecast to reach a readjusted size of US$ 454 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 105
USD 4250.00
(Single User License)
The global Microbiota Transplantation Service market was valued at US$ 316 million in 2025 and is anticipated to reach US$ 454 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 136
USD 2900.00
(Single User License)
The global market for Microbiota Transplantation Service was estimated to be worth US$ 316 million in 2025 and is projected to reach US$ 454 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 130
USD 3950.00
(Single User License)
The global Microbiota Transplantation Service market is projected to grow from US$ 301 million in 2024 to US$ 433 million by 2031, at a CAGR of 5.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-16
Pages: 151
USD 4900.00
(Single User License)
The global market for Microbiota Transplantation Service was valued at US$ 301 million in the year 2024 and is projected to reach a revised size of US$ 433 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published Date: 2025-07-16
Pages: 94
USD 2900.00
(Single User License)
The global Microbiota Transplantation Service market size was US$ 301 million in 2024 and is forecast to a readjusted size of US$ 433 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published Date: 2025-07-16
Pages: 103
USD 4250.00
(Single User License)
The global Microbiota Transplantation Service market is projected to grow from US$ 316 million in 2025 to US$ 454 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 147
The global Microbiota Transplantation Service market size was US$ 316 million in 2025 and is forecast to reach a readjusted size of US$ 454 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 105
The global Microbiota Transplantation Service market was valued at US$ 316 million in 2025 and is anticipated to reach US$ 454 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-03-12
Pages: 136
The global market for Microbiota Transplantation Service was estimated to be worth US$ 316 million in 2025 and is projected to reach US$ 454 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-03-09
Pages: 130
The global Microbiota Transplantation Service market is projected to grow from US$ 301 million in 2024 to US$ 433 million by 2031, at a CAGR of 5.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-16
Pages: 151
The global market for Microbiota Transplantation Service was valued at US$ 301 million in the year 2024 and is projected to reach a revised size of US$ 433 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published: 2025-07-16
Pages: 94
The global Microbiota Transplantation Service market size was US$ 301 million in 2024 and is forecast to a readjusted size of US$ 433 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published: 2025-07-16
Pages: 103
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now